AI Therapeutics Stock

ai-therapeutics.comHealthcare / BioTech & PharmaFounded: 2013Funding to Date: $98MM

AI Therapeutics is the developer of a deep learning platform designed to synthesize public and proprietary data on drugs and diseases and finds new indications for our library of new chemical entities.

Register To Buy and Sell Shares

For more details on financing and valuation for AI Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access AI Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like AI Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Henri Lichenstein Ph.D
President, CSO & Chief Executive Officer
Jonathan Rothberg Ph.D
Co-Founder & Board Member
Paul Beckett Ph.D
Senior Director of Drug Discovery
Tian Xu Ph.D
Co-Founder & Scientific Advisor

Board Members

George Rehm JD
Jonathan Rothberg Ph.D
Gregg Fergus
4Catalyzer

Frequently Asked Questions About AI Therapeutics’ Stock

plusminus
Can you buy AI Therapeutics’ stock?
AI Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy AI Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell AI Therapeutics’ stock?
Yes, you can sell stock of a private company like AI Therapeutics. Forge can help you sell your AI Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is AI Therapeutics’ stock price?
AI Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access AI Therapeutics’ private market stock price with Forge Data.
plusminus
What is AI Therapeutics’ stock ticker symbol?
AI Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

AI Therapeutics : Announces that a Common LAM-002 Mechanism in Cancer and Neurodegenerative Diseases Shows Antitumor Activity in the Clinic and Hope for ALS
LAM Therapeutics Raises $58M in Series C Funding |FinSMEs
LAM Therapeutics, a Guilford, Conn.-based developer of drugs for cancer and rare diseases, closed $58M in Series C financing. The backers were not disclosed. The company intends to use the funds to advance its drugs. Led by Henri Lichenstein, Ph.D., and Dr. Tian Xu, LAM Therapeutics develops precision therapeutics and companion diagnostics for cancer and …
Updated on: May 20, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.